Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

BACKGROUND: Patient‐derived organoid (PDO) models are highly valuable and have potentially widespread clinical applications. However, limited information is available regarding organoid models of non‐small cell lung cancer (NSCLC). This study aimed to characterize the consistency between primary tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Chen, Jing‐Hua, Chu, Xiang‐Peng, Zhang, Jia‐Tao, Nie, Qiang, Tang, Wen‐Fang, Su, Jian, Yan, Hong‐Hong, Zheng, Hong‐Ping, Chen, Ze‐Xin, Chen, Xin, Song, Meng‐Meng, Yi, Xin, Li, Pan‐Song, Guan, Yan‐Fang, Li, Gang, Deng, Chu‐Xia, Rosell, Rafael, Wu, Yi‐Long, Zhong, Wen‐Zhao
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396373/
https://ncbi.nlm.nih.gov/pubmed/32633046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados